Peter Heerma

CIK 1789617 · CHIEF COMMERCIAL OFFICER · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.32M

Companies

2

Total Filings

29

Lifetime Open-Market Net

-$2.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX CHIEF COMMERCIAL OFFICER 140,684 $52.04 $7.32M -$1.96M 26 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted Chief Commercial Officer 44,517 -$83.7K 3 2020-10-05

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-05 TVTX Sell (S) −3,058 -$75.7K EDGAR
2021-08-17 TVTX Mixed +3,093 -$24.1K EDGAR
2021-02-09 TVTX Sell (S) −2,250 -$70.9K EDGAR
2021-02-05 TVTX Grant (A) +4,500 $0 EDGAR
2021-02-03 TVTX Sell (S) −1,126 -$33.6K EDGAR
2021-01-25 TVTX Grant (A) +15,000 $0 EDGAR
2020-10-05 Travere Therapeutics, Inc. (RTRX) Delisted Sell (S) −4,376 -$83.7K EDGAR
2020-01-31 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +9,000 $0 EDGAR
2019-10-02 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +35,000 $0 EDGAR
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.